Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,755 | 25,442 | 40,362 | 57,473 | 32,235 |
| Marketable Securities | N/A | N/A | N/A | N/A | 7,300 |
| Inventories | N/A | 2,281 | N/A | 3,408 | 3,028 |
| Other current assets | 19,692 | 4,632 | 5,534 | 5,169 | 5,615 |
| TOTAL | $81,447 | $32,355 | $45,896 | $66,050 | $48,178 |
| Non-Current Assets | |||||
| PPE Net | 7,591 | 7,998 | 8,738 | 9,448 | 10,120 |
| Intangibles | 8,586 | 9,329 | 9,627 | 9,735 | 9,862 |
| Other Non-Current Assets | 749 | 749 | 749 | 0 | 0 |
| TOTAL | $16,926 | $18,076 | $19,114 | $19,183 | $19,982 |
| Total Assets | $98,373 | $50,431 | $65,010 | $85,233 | $68,160 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,772 | 11,313 | 11,669 | 1,750 | 1,575 |
| Accounts payable and accrued liabilities | 7,519 | 5,750 | 4,806 | 3,060 | 7,614 |
| Accrued Expenses | 7,056 | 12,142 | 9,122 | 11,240 | 8,775 |
| Other current liabilities | 136 | 136 | 132 | 234 | N/A |
| TOTAL | $28,089 | $40,544 | $37,684 | $28,967 | $30,614 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 110 | 142 | 10,150 | 10,675 |
| Deferred Revenues | 542 | 8,914 | 9,247 | 9,345 | 9,342 |
| Other Non-Current Liabilities | 13,623 | 17,875 | 11,817 | 11,848 | 6,157 |
| TOTAL | $15,576 | $120,638 | $116,342 | $128,575 | $125,838 |
| Total Liabilities | $43,665 | $161,182 | $154,026 | $157,542 | $156,452 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,788 | 110,681 | 109,224 | 108,958 | 108,808 |
| Common Shares | 111 | 109 | 109 | 109 | 87 |
| Retained earnings | -382,658 | -542,006 | -518,608 | -500,600 | -479,788 |
| TOTAL | $54,708 | $-110,751 | $-89,016 | $-72,309 | $-88,292 |
| Total Liabilities And Equity | $98,373 | $50,431 | $65,010 | $85,233 | $68,160 |